- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05762718
Validation of a Food Frequency Questionnaire: VioScreen
March 6, 2023 updated by: University of Colorado, Denver
The purpose of this study is to learn more about how well a questionnaire about food intake works.
The study team will compare questionnaire responses to several other measurements of food intake.
There is a special emphasis on fruit and vegetable intake.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
69
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Children's Hospital Colorado
-
Contact:
- Carina Venter, PhD
- Email: carina.venter@childrenscolorado.org
-
Principal Investigator:
- Carina Venter, PhD
-
Denver, Colorado, United States, 80204
- Denver Health
-
Contact:
- Stefka Fabbri, MD
- Email: stefka.fabbri@dhha.org
-
Principal Investigator:
- Stefka Fabbri, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
pregnant women and women of child-bearing age
Description
Inclusion Criteria:
- Age 18-40 as we are aiming to recruit women of child-bearing age
- Pregnant women up to 26 weeks' gestation
- Women assigned female sex at birth who are not pregnant
Exclusion Criteria:
- Women below the age of 18 or over the age of 40 years
- Pregnant women more than 26 weeks' gestation at the time of enrollment
- Women who are experiencing limited or reduced food intake related to nausea will not be approached for recruitment and are considered ineligible
- Women who are unwilling to participate in the study due to time commitment or other reasons
- Women whose capacity for study compliance is diminished due to conditions such as active untreated substance use disorder, untreated/uncontrolled schizophrenia, bipolar disorder, active psychosis will not be approached for recruitment and are considered ineligible
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concurrent validity of VioScreen against 24-hour recalls
Time Frame: 6 weeks
|
Concurrent validity measures how a new test compares against a validated test, called the criterion or "gold standard."
|
6 weeks
|
Test-retest reliability of VioScreen
Time Frame: one month
|
Test-retest reliability is a measure of reliability obtained by administering the same test twice over a period of time to a group of individuals.
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concurrent validity of VioScreen against Veggie Meter
Time Frame: 6 weeks
|
Concurrent validity measures how a new test compares against a validated test, called the criterion or "gold standard."
|
6 weeks
|
Concurrent validity of VioScreen against Fruit and Vegetable Screener
Time Frame: 6 weeks
|
Concurrent validity measures how a new test compares against a validated test, called the criterion or "gold standard."
|
6 weeks
|
Test-retest reliability of Veggie Meter
Time Frame: one month
|
Test-retest reliability is a measure of reliability obtained by administering the same test twice over a period of time to a group of individuals.
|
one month
|
Test-retest reliability of Fruit and Vegetable Screener
Time Frame: one month
|
Test-retest reliability is a measure of reliability obtained by administering the same test twice over a period of time to a group of individuals.
|
one month
|
Concurrent validity of Veggie Meter against 24-hour recalls
Time Frame: 6 weeks
|
Concurrent validity measures how a new test compares against a validated test, called the criterion or "gold standard."
|
6 weeks
|
Concurrent validity of Fruit and Vegetable Screener against 24-hour recalls
Time Frame: 6 weeks
|
Concurrent validity measures how a new test compares against a validated test, called the criterion or "gold standard."
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carina Venter, PhD, University of Colorado, Denver
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2023
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
December 1, 2023
Study Registration Dates
First Submitted
February 22, 2023
First Submitted That Met QC Criteria
March 6, 2023
First Posted (Estimate)
March 10, 2023
Study Record Updates
Last Update Posted (Estimate)
March 10, 2023
Last Update Submitted That Met QC Criteria
March 6, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 22-0904
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Not Determined
-
Cairo UniversityRecruiting
-
BeiGeneCompletedNot DeterminedAustralia, China
-
University of LouisvilleNorton HealthcareRecruitingOrgan Perfusion Determined by Using NIRS Post Transcatheter PDA Occlusion or Medical Closure of PDAUnited States
-
Rutgers, The State University of New JerseyUtah State UniversityCompletedIncreasing Functional Communicative Behavior | Decreasing Destructive Behavior | Analysis of Treatment Dosage | Empirically Determined Reinforcement Schedule ThinningUnited States
-
University of East AngliaUniversity of Hertfordshire; London South Bank University; Health Education England... and other collaboratorsCompleted
-
University of PennsylvaniaCarnegie Mellon UniversityCompletedNot Condition-specific
-
Milton S. Hershey Medical CenterCompleted
-
University of ValenciaUniversity of TwenteCompletedNot Flourishing PopulationSpain, Netherlands
-
SocraTec R&D GmbHSocraMetrics GmbHCompletedBioavailability, Therapeutical Indication Not StudiedGermany